- The market is witnessing significant traction from emerging economies, where rising healthcare investments and improved access to advanced therapeutics are creating substantial growth opportunities
- Key players are focusing on innovation in packaging formats such as prefilled syringes, vials, and ampoules, to cater to the growing need for user-friendly and safe parenteral drug delivery systems
- North America dominated the parenteral packaging market with the largest revenue share of 39.84% in 2024, driven by rising demand for biologics, increasing chronic disease prevalence, and stringent pharmaceutical packaging regulations
- The Asia-Pacific region is expected to witness the highest growth rate in the global parenteral packaging market, driven by increasing investments in healthcare infrastructure, a rising prevalence of chronic diseases, and expanding pharmaceutical manufacturing activities, particularly in countries such as China and India
- The vials segment dominated the market with the largest revenue share in 2024, driven by their widespread use in storing vaccines, biologics, and injectables. Vials offer strong compatibility with a variety of drug formulations and ensure superior protection against contamination, making them a standard choice among pharmaceutical manufacturers. The durability, reusability, and proven performance of vials in clinical and commercial applications contribute significantly to their continued dominance in the market
